节点文献

Orai1上调促进血管平滑肌钙化表型转化

Up-regulation of Orai1 promotes calcification-associated phenotypic transformation in vascular smooth muscle

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 梁美英周维妍肖佩仪王昊杨慧饶芳邓春玉

【Author】 LIANG Meiying;ZHOU Weiyan;XIAO Peiyi;WANG Hao;YANG Hui;RAO Fang;DENG Chunyu;School of Pharmaceutical Sciences, Southern Medical University;Guangdong Provincial Key Laboratory of Clinical Pharmacology, Department of Medical Research, Guangdong Academy of Medical Sciences,Guangdong Provincial People’s Hospital, Southern Medical University;The Second Affiliated Hospital of Nanchang University;

【通讯作者】 邓春玉;

【机构】 南方医科大学药学院南方医科大学附属广东省人民医院(广东省医学科学院)基础医学研究中心,广东省临床药理学重点实验室南昌大学第二附属医院

【摘要】 目的:探讨Ca2+释放激活钙通道蛋白1(Orai1)在大鼠主动脉钙化中的作用机制。方法:取30只8周龄的雄性SD大鼠(200~250 g),随机分为正常生长培养液(GM)组、高钙磷钙化培养液(CM)组、溶剂对照二甲基亚砜组、Orai1抑制剂3,5-双(三氟甲基)吡唑衍生物(BTP2)处理组及内质网应激(ERS)抑制剂4-苯基丁酸(4-PBA)处理组,每组6只。制备离体主动脉环,给予10 mmol/L β-甘油磷酸和3 mmol/L CaCl2刺激7 d构建主动脉钙化模型,造模同时给予BTP2或4-PBA干预。采用茜素红和冯·科萨染色评估主动脉钙化的严重程度;Western blot检测Orai1、成骨分化相关指标[Runt相关转录因子2(RUNX2)和骨形态发生蛋白2(BMP2)]、收缩表型指标[平滑肌肌球蛋白重链(SMMHC)和平滑肌蛋白22α(SM22α)]和ERS信号通路相关蛋白[磷酸化真核生物翻译起始因子2α(peIF2α)和活化转录因子4(ATF4)]的表达水平;基于Fluo-4 AM负载的细胞内Ca2+成像技术,利用激光共聚焦显微镜测量血管平滑肌细胞内游离Ca2+浓度([Ca2+]i)的变化,观察Orai1抑制剂BTP2对钙池操纵性钙(SOC)通道介导的钙内流的影响;血管张力实验观察BTP2对SOC通道介导的血管收缩的影响。结果:茜素红和冯·科萨染色结果显示,与GM组相比,CM组血管钙化程度显著增强(P<0.01);Western blot结果显示,与GM组相比,CM组RUNX2和BMP2蛋白表达显著上调(P<0.05或P<0.01),Orai1蛋白表达显著上调(P<0.05),同时p-eIF2α和ATF4蛋白表达亦显著上调(P<0.01或P<0.05)。与CM组相比,给予10??mol/L BTP2干预后,血管钙化程度显著减轻(P<0.05);且逆转了RUNX2和BMP2蛋白表达(P<0.01),同时下调p-eIF2α和ATF4蛋白表达(P<0.01);此外,与CM组相比,给予5 mmol/L 4-PBA干预逆转了RUNX2和BMP2蛋白表达(P<0.05或P<0.01);激光共聚焦显微镜检测血管平滑肌细胞[Ca2+]i结果表明,BTP2显著抑制了SOC通道介导的钙内流(P<0.05);血管张力测定结果显示,BTP2显著抑制了SOC通道介导的血管收缩(P<0.05)。结论:在大鼠主动脉钙化模型中Orai1表达上调,Orai1抑制剂BTP2可抑制SOC通道介导的钙内流和血管收缩,同时减轻主动脉环成骨样表型转化,其机制可能与ERS有关。

【Abstract】 AIM: To investigate the mechanism of Ca2+ release-activated calcium channel protein 1(Orai1) in rat aortic calcification. METHODS: Thirty 8-week-old male SD rats(200 to 250 g) were randomized into 5 groups: growth medium(GM) group, calcification medium(CM) group, dimethyl sulfoxide group, Orai1 inhibitor 3,5-bis(trifluoromethyl)pyrazole derivative(BTP2) group, and endoplasmic reticulum stress(ERS) inhibitor 4-phenylbutyrate(4-PBA) group. Then, isolated aortic rings were prepared and stimulated with 10 mmol/L β-glycerophosphate and 3 mmol/L CaCl2 for 7 d to establish a calcification model. Concurrently, BTP2 or 4-PBA intervention was performed during modeling. The severity of calcification was evaluated via alizarin red and von Kossa staining. Additionally, the expression levels of Orai1, osteogenic differentiation markers [Runt-related transcription factor 2(RUNX2) and bone morphogenetic protein 2(BMP2)], contractile markers [smooth muscle myosin heavy chain(SMMHC) and smooth muscle protein 22α(SM22α)], and key molecules involved in the ERS signaling pathway, especially phosphorylated eukaryotic translation initiation factor 2α(p-eIF2α) and activating transcription factor 4(ATF4), were assessed by Western blot. By utilizing laser confocal microscopy, intracellular free Ca2+ concentration([Ca2+]i) in vascular smooth muscle cells(VSMCs) was monitored using Fluo-4 AM fluorescent probes. The effect of BTP2 on store-operated calcium(SOC) channel-mediated vasoconstriction was further evaluated using an in vitro vascular tension assay. RESULTS: The results of alizarin red and von Kossa staining revealed a marked increase in aortic ring calcification following stimulation with high levels of calcium and phosphate(P<0. 01). In an in vitro rat aortic ring calcification model, there was significant up-regulation of Orai1 protein expression(P<0. 05), accompanied by elevated levels of osteogenic differentiation-related markers RUNX2 and BMP2(P<0. 05 or P<0. 01). In addition, the expression of ERS pathway markers was markedly elevated, especially peIF2α and ATF4(P<0. 01 or P<0. 05). Treatment with BTP2 resulted in significant attenuation of aortic ring calcification(P<0. 05) and reversal of osteogenic differentiation markers, including RUNX2 and BMP2 protein expression(P<0. 01), while concurrently down-regulating the ERS pathway proteins p-eIF2α and ATF4(P<0. 01). Furthermore, compared with the CM group, treatment with 4-PBA reversed the expression levels of RUNX2 and BMP2(P<0. 05 or P<0. 01). The assessment of [Ca2+]i in VSMCs indicated that BTP2 significantly inhibited SOC channel-mediated calcium influx(P<0. 05). In vitro vascular tension assays demonstrated that BTP2 significantly inhibited SOC channel-mediated vasoconstriction(P<0. 05). CONCLUSION: An aortic ring calcification model is successfully developed, demonstrating up-regulation of Orai1 expression. Treatment with Orai1 inhibitor BTP2 effectively suppresses SOC channel-mediated calcium influx and vasoconstriction, consequently inhibiting aortic calcification. This mechanism may be associated with ERS.

【基金】 国家自然科学基金资助项目(No.82370411)
  • 【文献出处】 中国病理生理杂志 ,Chinese Journal of Pathophysiology , 编辑部邮箱 ,2026年05期
  • 【分类号】R54
  • 【下载频次】20
节点文献中: